Literature DB >> 28692864

Serum IL-10, IL-17 and IL-23 levels as "bioumoral bridges" between dyslipidemia and atopy.

S Manti1, S Leonardi2, I Panasiti3, T Arrigo3, C Salpietro3, C Cuppari3.   

Abstract

BACKGROUND: Although several studies suggest a possible link between dyslipidemia and atopy, literature findings are still unclear.
OBJECTIVE: The aim of the study was to investigate the relationship between dyslipidemia and atopy in a pediatric population affected by dyslipidemia or dyslipidemia/atopic predisposition.
MATERIALS AND METHODS: Children with dyslipidemia, dyslipidemia and atopy as well as healthy children were recruited. Serum total IgE, IL-10, IL-17, and IL-23 levels as well as fasting lipid values (total cholesterol, LDL, HDL and triglycerides) were performed on all enrolled children.
RESULTS: The present study evaluated 23 patients affected by dyslipidemia, 26 patients affected by atopy and dyslipidemia and, 22healthy children. Serum total IgE levels significantly related also with serum cholesterol levels: positively with total cholesterol (p<0.05), LDL (p<0.05), and tryglicerides (p<0.001), but negatively with HDL (p<0.05). Serum levels of IL-10 were lower in children with atopy and dyslipidemia than patients with dyslipidemia (p<0.001). Serum IL-10 levels significantly related also with serum cholesterol levels: negatively with total cholesterol (p<0.001), LDL (p<0.05), and triglycerides (p<0.05), but positively with HDL (p<0.05). Serum IL-17 and IL-23 levels showed the same trend. They were significantly higher in children with atopy and dyslipidemia than patients with dyslipidemia (p<0.001). In particular, serum IL-17 and IL-23 values positively correlated with serum total IgE levels (p<0.05); serum total cholesterol levels (p<0.001); serum LDL levels (p<0.001); serum triglycerides levels (p<0.05). Although not statistically significant, an inverse correlation has been noted between serum IL-17, IL-23 and HDL levels.
CONCLUSIONS: These findings support the notion that dyslipidemia and atopic predisposition share the same immune pathways as well as they offer new insights in the complex crosstalk between hyperlipidemia and atopy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atopy; Children; Dyslipidemia; IL-10; IL-17; IL-23

Mesh:

Substances:

Year:  2017        PMID: 28692864     DOI: 10.1016/j.cyto.2017.07.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Vitamin C and B3 as new biomaterials to alter intestinal stem cells.

Authors:  Yijun Qi; Jo Lohman; Kaitlin M Bratlie; Nathan Peroutka-Bigus; Bryan Bellaire; Michael Wannemuehler; Kyoung-Jin Yoon; Terrence A Barrett; Qun Wang
Journal:  J Biomed Mater Res A       Date:  2019-05-23       Impact factor: 4.396

2.  High density lipoprotein inhibited group II innate lymphoid cells proliferation and function in allergic rhinitis.

Authors:  Shengli Gao; Qingxiang Zeng; Yinhui Zeng; Yiquan Tang; Wenlong Liu
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-11       Impact factor: 3.373

Review 3.  Measuring inflammation in paediatric severe asthma: biomarkers in clinical practice.

Authors:  Amelia Licari; Sara Manti; Riccardo Castagnoli; Salvatore Leonardi; Gian Luigi Marseglia
Journal:  Breathe (Sheff)       Date:  2020-03

4.  Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile.

Authors:  Hai-Tao Huang; Xue-You Zhang; Cheng Zhang; Qi Ling; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

5.  Lipid Profile and IL-17A in Allergic Rhinitis: Correlation With Disease Severity and Quality of Life.

Authors:  Dina Sheha; Lobna El-Korashi; Amany M AbdAllah; Marwa M El Begermy; Doaa M Elzoghby; Amira Elmahdi
Journal:  J Asthma Allergy       Date:  2021-02-04

6.  Increased Adipose Tissue Expression of IL-23 Associates with Inflammatory Markers in People with High LDL Cholesterol.

Authors:  Shihab Kochumon; Amal Hasan; Fatema Al-Rashed; Sardar Sindhu; Reeby Thomas; Texy Jacob; Amnah Al-Sayyar; Hossein Arefanian; Ashraf Al Madhoun; Ebaa Al-Ozairi; Fawaz Alzaid; Heikki A Koistinen; Fahd Al-Mulla; Jaakko Tuomilehto; Rasheed Ahmad
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

7.  Obesity, Lipid Profile and Cytokines in Spondyloarthritis.

Authors:  Maroua Slouma; Wided Lahmer; Lobna Kharrat; Khaoula Ben Ali; Aymen Tezeghdenti; Leila Metoui; Rim Dhahri; Ezzedine Ghazouani; Imen Gharsallah; Bassem Louzir
Journal:  Indian J Endocrinol Metab       Date:  2022-09-20

Review 8.  Aberrations in Lipid Expression and Metabolism in Psoriasis.

Authors:  Julia Nowowiejska; Anna Baran; Iwona Flisiak
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.